TherapeuticsMD Stock Price - TXMD

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
After Hours
Last Trade
Last: $ 2.74 ▲ 0.01 (0.37%)
Company Name Stock Ticker Symbol Market Type
TherapeuticsMD Inc TXMD NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.07 -2.50% 2.73 2.90 2.70 2.78 2.80 19:28:37
Bid Price Ask Price Spread Spread % News
2.66 2.74 0.08 2.92% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
7,545 1,996,968 $ 2.78 $ 5,548,434 3,517,912 1.82 - 6.94
Last Trade Time Type Quantity Stock Price Currency
17:42:58 formt 800 $ 2.74 USD

TherapeuticsMD Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 658.54M 241.22M $ -132.62M -0.59 - 216.87M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 2.41k 10.10%

more financials information »

TherapeuticsMD News

Loading Messages....

Latest TXMD Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TXMD Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week2.973.152.62.79443M-0.24-8.08%
1 Month2.213.311.822.57794M0.5223.53%
3 Months2.963.541.822.57854M-0.23-7.77%
6 Months5.426.091.823.47803M-2.69-49.63%
1 Year5.636.941.824.28053M-2.9-51.51%
3 Years5.257.661.824.96363M-2.52-48.00%
5 Years5.257.661.824.96363M-2.52-48.00%

TherapeuticsMD Description

TherapeuticsMD Inc is a major drug manufacturing with a focus on creating and commercializing products targeted exclusively for women. The company intends to commercialize advanced hormone therapy pharmaceutical products. TherapeuticsMD's drug candidates that have completed clinical trials are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and discomfort. The company relies on third parties for the production of clinical and commercial quantities of its drug candidates.


Your Recent History
NASDAQ
TXMD
Therapeuti..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.